| Similar Articles |
|---|
 |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector   |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
National Real Estate Investor
June 1, 2003
H. Lee Murphy |
Who's Behind Biotech? There is a niche in the office market where vacancies are a fraction of the national rate, rents are way above average, and prospects for growth actually exist. It is the specialized (and regionally concentrated) business of supplying space to the biotech and life sciences industry. |
IndustryWeek
November 1, 2002
Tonya Vinas |
Questioning Biotech's Benefits While most communities are investing to attract or grow biotechnology companies, a recent report concludes that only a handful of cities will benefit in the long run. |
Commercial Investment Real Estate
May/Jun 2005
Bell & Drummond |
Biotech Boom Biotech tenants have specific needs for lab/office space, but they do not need a physical link to a city's business center. In addition to biotech, the nanotech and biopharmaceutical industries are also growing quickly. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
Bio-IT World
October 2006
Thomas G. Morr |
Eight Essential Elements for Commercial Success For life sciences companies both young and old, location is one of the critical success factors. With that in mind, here are eight essential considerations for life sciences executives when they are thinking of starting a business or opening a new location. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Turning Sugar into Science The landmark building that housed the New England Confectionery Company in Revere, Mass. is being transformed into the new headquarters for the Novartis Institutes for BioMedical Research. |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
IndustryWeek
September 16, 2009
Jill Jusko |
In Search Of America's Best Manufacturing Locations Forget about 'one site fits all.' Look for 'one site fits me.' |
Pharmaceutical Executive
April 10, 2014
Christini & Kaitin |
Regional Trends in Bioinnovation Investment Can the Cambridge model be duplicated? |
Bio-IT World
July 14, 2004 |
Not Just a Day at the Beach Joseph Panetta recalls leaving the comfort of a pharma job in Philadelphia for a position in biotech in San Diego, whose fledgling biotech community survived stormy nascent years to mushroom into a biotech hotbed. |
Job Journal
July 15, 2007
Rich Heintz |
Solano County Fast-growing Solano County offers affordable living and jobs aplenty. |
Reason
May 2007
John F. Sugg |
The Folly of Southern Hospitality Dixie leads the way in lavish corporate subsidies. As other parts of the country follow suit, it's time to ask whether such incentives work. |
The Motley Fool
January 28, 2011
Luke Timmerman |
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars Biotech drugs will soon dominate the pharmaceutical industry, and Merck is playing catch-up. |
Bio-IT World
April 2006
Laura Huckabee-Jennings |
Southern Emergence Why Huntsville, Alabama, will be the next biotech hotbed. |
Pharmaceutical Executive
January 1, 2011 |
The San Diego Story San DIego works as a locus for risky investments in the big ideas that lead to biotech breakthroughs |
Job Journal
August 8, 2004
Rich Heintz |
Biotech's Winning Formula for Steady Job Growth Deep pockets are creating expanding opportunities and biotechnology is helping to put America back to work. |
National Real Estate Investor
February 1, 2007
Morris Newman |
Biotech Clouds Don't Obscure San Diego's Sunny Future Nothing in life is perfect, but the suburban office markets of San Diego County have little to complain about at present in spite of the tepid biotech sector, once the crown jewel of the area's economy. |
Food Engineering
July 30, 2009
Carolyn Chapin |
The Changing Face of Site Selection Food and beverage manufacturers must plan for change when selecting processing facility sites in today's volatile economy. |
BusinessWeek
November 10, 2003
Arlene Weintraub |
Biotech Startups: Take Your Time Until products are close to approval, the public shouldn't share the risk |
IndustryWeek
August 1, 2002
Tonya Vinas |
Locations -- R.I. Plants To Supply Key Drug Immunex Corp. chooses West Greenwich for BioNext Project, which will produce Enbrel and other drugs for the growing biotech company. |
BusinessWeek
September 27, 2004
Kerry Capell |
How Dublin Keeps Big Pharma Happy By providing cheap yet educated workers and giving tax breaks to big investors, the Irish have turned their country into a major drug manufacturing center. |
The Motley Fool
July 15, 2010
Ryan McBride |
Glaxo's Tempero Pharma Advances on Hot Niche of Immunology Staking claim in emerging fields. |
CFO
April 1, 2008
Kate O'Sullivan |
Business Outlook Survey CFOs are retrenching as the United States enters what could be a lengthy recession. |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
BusinessWeek
March 7, 2005
Arlene Weintraub |
Where VCs Fear To Tread Angel investors are filling a critical gap by providing early backing for biotechs. |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
IndustryWeek
February 15, 2012
Adrienne Selko |
Ohio's Secret -- Business-Friendly Tax Code Has tax reform helped attract manufacturers to state? |
Entrepreneur
March 2006
C.J. Prince |
You Be the Judge Are tax incentives to attract businesses unconstitutional? |
Commercial Investment Real Estate
Sep/Oct 2009
Sara Drummond |
Teams Work Collaboration is the key to successful development projects. |
Chemistry World
April 21, 2009
Matt Wilkinson |
Survival of the fittest While the pharmaceutical and biopharmaceutical sectors in general are outperforming broader stock market trends, many early stage companies are desperately trying to conserve cash and raise money to keep going. |
Fast Company
February 2009
Elizabeth Svoboda |
Wyeth's Multibillion-dollar Biotech Bet Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits. |
CFO
January 10, 2007
Kate O'Sullivan |
Give & Take Until more states learn to make peace with their dual missions -- raising revenue while creating a hospitable environment for business -- confusion seems likely to reign. And the tax director's job will continue to demand extreme flexibility and patience. |
National Real Estate Investor
May 1, 2006
F. R. Skinner |
Bulking Up On Biotech Investing in the development of a highly unique, medical-grade building is only going to appeal to a select niche of investors. But with biotech returns averaging some 1% to 2% higher than the general office market, it is a smart play for investors wanting a diversified portfolio. |
Fast Company
January 2001
Bill Breen |
Where Are You on the Talent Map? What's the secret to power hiring? Location, location, location. If you want to attract the right kind of people, it's not enough to be the right kind of company. Your company needs to be in the right kind of place... |
The Motley Fool
June 21, 2010
Erin Kutz |
Curis Misses Mark in Drug Trial; Genzyme Elects Board; GTC Cuts Jobs; and More Boston-Area Life Sciences News These drug and biomedical companies made news last week. |
Commercial Investment Real Estate
Sep/Oct 2015
Daniel B. Cromwell |
Economic Development Incentives These tools can help sweeten the deal. |
Inc.
November 2003
Bobbie Gossage |
Smart Set An educated work force and bargain university research lab facilities lure entrepreneurs to Lawrence, Kansas. |
BusinessWeek
May 28, 2009
Catherine Arnst |
Make-or-Break Time for Cancer Drugs Strong presentations at the key oncology conference in late May will be crucial for struggling biotechs. |
Fast Company
November 1, 2007
Tinker Ready |
Drug Flow and Deal Flow The news at this year's Biotech Investing confab will focus on Big Pharma companies, as they take a more active role in developing early-stage drugs. |
BusinessWeek
August 7, 2006
Aili McConnon |
Richard Florida: Geography Is Destiny If you're not in a creative city, says a Carnegie Mellon University professor, you won't attract top talent. |
Pharmaceutical Executive
December 1, 2008
Walter Armstrong |
The New Deals Everything you wanted to know about the year's most important deals, and what to watch for in the future. |
Bio-IT World
May 19, 2004
Barbara Depompa |
Surging in Seattle Laid-back coastal-mountain lifestyle bolsters Northwestern biotech company. |
Knowledge@Wharton
March 26, 2003 |
Health Care Finance Industry Plagued by Lack of Funding, Focus In today's health care finance environment, early financing rounds are harder to fund and the market for initial public financings is dead, with no revival expected anytime soon. |
Pharmaceutical Executive
May 1, 2005 |
Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short. |
IndustryWeek
November 1, 2002
Peter Strozniak |
Incentives Stay -- For Now As U.S. states wrestle with budget deficits, they're working to keep incentives aimed at industry in place. |
